A
53
7
HCA
59
-3
NTAP
53
-2
EXR
24
-4
CHRW
71
-2
AMG
75
-4
HRL
23
-9
JCI
54
-2
PBI
63
-3
HUM
41
-5
DTE
40
-5
ABBV
55
-4
WAT
57
-2
WY
51
-6
MDT
53
-2
KHC
29
-2
CINF
58
-2
DOV
63
-6
DOW
40
-2
NWS
52
-4
A
53
7
HCA
59
-3
NTAP
53
-2
EXR
24
-4
CHRW
71
-2
AMG
75
-4
HRL
23
-9
JCI
54
-2
PBI
63
-3
HUM
41
-5
DTE
40
-5
ABBV
55
-4
WAT
57
-2
WY
51
-6
MDT
53
-2
KHC
29
-2
CINF
58
-2
DOV
63
-6
DOW
40
-2
NWS
52
-4
Financhill
Back

Genomma Lab Internacional SAB de CV 10K Form

Buy
56

GNMLF
Genomma Lab Internacional SAB de CV

Last Price:
$1.06
Seasonality Move:
-0.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GNMLF News And Ratings

See the #1 stock for the next 7 days that we like better than GNMLF

GNMLF Financial Statistics

Sales & Book Value

Annual Sales: $1B
Cash Flow: $7.5M
Price / Cash Flow: 26.06
Annual Sales: $0.61
Price / Book: 1.72

Profitability

EPS (TTM): 0.09160
Net Income (TTM): $89.5M
Gross Margin: $650.9M
Return on Equity: 15.81%
Return on Assets: 7.39%

Genomma Lab Internacional SAB de CV Earnings Forecast

Key Genomma Lab Internacional SAB de CV Financial Ratios

  • The Gross Profit Margin over the past 20 years for GNMLF is 64.12%.
  • The Selling, General & Administrative Expenses for GNMLF have been equal to 43.29% of Gross Profit Margin.
  • The Interest Expense is 42.46% of Operating Income.
  • The Net Earning history of GNMLF is 11.24% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

Genomma Lab Internacional SAB de CV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: GNMLF
Website: genommalab.com

Debt

Debt-to-Equity Ratio: 0.67
Current Ratio: 1.84
Quick Ratio: 1.05

Price-to-Earnings

Trailing P/E Ratio: 12.73
Forward P/E Ratio: 0

GNMLF Technical Analysis vs Fundamental Analysis

Buy
56
Genomma Lab Internacional SAB de CV (GNMLF) is a Buy

Is Genomma Lab Internacional SAB de CV a Buy or a Sell?